
NASDAQHealthcareMedical - Healthcare Information Services
最新数据
US$20.33
−US$0.09 · -0.44%
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
前收盘价
US$20.33
−US$0.09 · -0.44%
盘前
US$20.25
−US$0.08 · -0.39%
10月12日 5:17 ET
盘中时间采用ET。市场数据可能有所延迟。
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
日内区间
当前US$20.33
52周区间
当前US$20.33
盘中时间采用ET。市场数据可能有所延迟。
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
日内区间
当前US$20.33
52周区间
当前US$20.33
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.37亿 USD | 1.43亿 USD | 1.49亿 USD | 1.52亿 USD | 1.48亿 USD |
| 销货成本 | 5999.5万 USD | 5693.3万 USD | 5601.5万 USD | 5704.9万 USD | 5235万 USD |
| 毛利 | 7739.5万 USD | 8612.7万 USD | 9256.5万 USD | 9451.9万 USD | 9560.4万 USD |
| 销售、一般及管理费用 | 5480.5万 USD | 4491.1万 USD | 4658万 USD | 4269.9万 USD | 3896万 USD |
| 营业费用 | 5480.5万 USD | 5093.3万 USD | 5252万 USD | 4797.6万 USD | 4533.4万 USD |
| 利息收入 | 11.1万 USD | 12.5万 USD | 82万 USD | 16.8万 USD | 1.4万 USD |
| 利息支出 | 476.2万 USD | 259.5万 USD | 86.2万 USD | 120.9万 USD | 166.7万 USD |
| 折旧和摊销 | 762.4万 USD | 602.2万 USD | 589.9万 USD | 527.7万 USD | 637.4万 USD |
| 营业利润 | 2259万 USD | 3519.4万 USD | 4004.5万 USD | 4654.3万 USD | 5027万 USD |
| 净利润 | 1160万 USD | 2478.3万 USD | 3097.1万 USD | 3180万 USD | 3746.6万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
年度分割调整后的每股现金分配。
US$0.52
2025年(完整年度)+8.3% 自从 2021
2026年(部分年度):US$0.48
US$0.48
2,021
US$0.84
2,022
US$1.48
2,023
US$0.48
2,024
US$0.52
2,025
US$0.48
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年9月25日 | US$0.16Quarterly | 2026年9月25日 | 2026年10月9日 |
股息 | 2026年6月26日 | US$0.16Quarterly | 2026年6月26日 | 2026年7月10日 |
股息 | 2026年3月27日 | US$0.16Quarterly | 2026年3月27日 | 2026年4月10日 |
股息 | 2025年12月26日 | US$0.16Quarterly | 2025年12月26日 | 2026年1月9日 |
股息 | 2025年9月26日 | US$0.12Quarterly | 2025年9月26日 | 2025年10月10日 |
股息 | 2025年6月27日 | US$0.12Quarterly | 2025年6月27日 | 2025年7月11日 |
除息 2026年9月25日
US$0.16
Quarterly
2026年9月25日登记 · 支付日 2026年10月9日
除息 2026年6月26日
US$0.16
Quarterly
2026年6月26日登记 · 支付日 2026年7月10日
除息 2026年3月27日
US$0.16
Quarterly
2026年3月27日登记 · 支付日 2026年4月10日
除息 2025年12月26日
US$0.16
Quarterly
2025年12月26日登记 · 支付日 2026年1月9日
除息 2025年9月26日
US$0.12
Quarterly
2025年9月26日登记 · 支付日 2025年10月10日
除息 2025年6月27日
US$0.12
Quarterly
2025年6月27日登记 · 支付日 2025年7月11日
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1043.4万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM641.97万0.01%787.4亿 USD0.19%US$278.94+0.49%
Dimensional - US Small Cap ETFDFAS332.04万0.01%338.69亿 USD0.31%US$78.35+0.32%
Vanguard Extended Market ETFVXF326.34万0.00%954亿 USD0.05%US$235+0.80%
WisdomTree U.S. SmallCap Dividend FundDES253.2万0.12%20.8亿 USD0.38%US$38.24-0.47%
U.S. Micro Cap Portfolio ETFDFMC244.33万0.03%75.58亿 USD0.43%US$57.813+0.20%
Fidelity Small-Mid Multifactor ETFFSMD226.05万0.09%24.9亿 USD0.15%US$49.96+0.48%
iShares Russell 2000 Growth ETFIWO225.94万0.02%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Dimensional - US Small Cap ETFDFAS
Vanguard Extended Market ETFVXF
WisdomTree U.S. SmallCap Dividend FundDES
U.S. Micro Cap Portfolio ETFDFMC
Fidelity Small-Mid Multifactor ETFFSMD
iShares Russell 2000 Growth ETFIWOAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。